Published in Health and Medicine Week, August 15th, 2005
EVIZON is a systemically delivered anti-angiogenic drug being developed to treat AMD.
The presentations were held at the 23rd annual meeting of the American Society of Retina Specialists (ASRS) in Montreal, Quebec, Canada.
Brian P. Connolly, MD, retina research services, Wills Eye Hospital, Philadelphia, Pennsylvania, presented clinical trial results,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.